Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

Clinical trial NCT07288177 · RECRUITING

Trial details

NCT number: NCT07288177
Sponsor: Genmab
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)

Start date: 2026-01-30
Primary completion: 2027-11-22
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.